Does RIBOCICLIB Cause Hepatotoxicity? 585 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 585 reports of Hepatotoxicity have been filed in association with RIBOCICLIB (KISQALI). This represents 2.1% of all adverse event reports for RIBOCICLIB.
585
Reports of Hepatotoxicity with RIBOCICLIB
2.1%
of all RIBOCICLIB reports
49
Deaths
113
Hospitalizations
How Dangerous Is Hepatotoxicity From RIBOCICLIB?
Of the 585 reports, 49 (8.4%) resulted in death, 113 (19.3%) required hospitalization, and 65 (11.1%) were considered life-threatening.
Is Hepatotoxicity Listed in the Official Label?
Yes, Hepatotoxicity is listed as a known adverse reaction in the official FDA drug label for RIBOCICLIB.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Hepatotoxicity?
METHOTREXATE (1,917)
ACETAMINOPHEN (1,557)
LEFLUNOMIDE (829)
HYDROXYCHLOROQUINE (715)
PREDNISONE (707)
RITUXIMAB (702)
ETANERCEPT (699)
ADALIMUMAB (674)
CYCLOPHOSPHAMIDE (632)
SULFASALAZINE (613)
Which RIBOCICLIB Alternatives Have Lower Hepatotoxicity Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN